Riskpilot← Back to searchSign inGet full accessKanenas 109 AB
ABDissolvedOrg 5567384515Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20070 employees
Revenue 2020
SEK 0
EBITDA margin
—
+121% vs 2019
Equity ratio
86.6%
Financial strength
Net profit 2020
SEK 2K
-96% vs 2019
| Revenue | SEK 0 | — |
| EBITDA | SEK 3K | +121% |
| Net profit | SEK 2K | -96% |
| Total assets | SEK 119K | -72% |
| Equity | SEK 103K | -74% |
| Employees | 0 | — |
Legal name
Kanenas 109 AB
Org number
5567384515
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
19 september 2007
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Company purpose
Bolaget skall bedriva mäkleriverksamhet med affärsrörelser inom databranschen för ekonomisystem och förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 968 | 997 | 160 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 173 | 94 | −8 | −14 | 3 |
| Depreciation & amort. | −62 | −62 | −0 | −0 | −0 |
| EBIT | 111 | 32 | −8 | −14 | 3 |
| Net financials | 7 | 70 | — | 84 | −1 |
| Profit before tax | 136 | 140 | 41 | 70 | 3 |
| Tax | −30 | −31 | −9 | −15 | −1 |
| Net profit | 106 | 109 | 32 | 55 | 2 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 667 | 717 | 444 | 432 | 119 |
| Equity | 387 | 445 | 427 | 401 | 103 |
| Long-term debt | 0 | 10 | 0 | 0 | 0 |
| Short-term debt | 194 | 212 | 17 | 30 | 16 |
| Total debt | 194 | 222 | 17 | 30 | 16 |
EBITDA margin
300000.0%
This company
15.8%
Market median
+1898634% vs market
20162020
Equity ratio
86.6%
This company
38.2%
Market median
+127% vs market
20162020
Return on equity
1.9%
This company
18.4%
Market median
-90% vs market
20162020
Net profit margin
200000.0%
This company
8.1%
Market median
+2469036% vs market
20162020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162020
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20162020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
| Board of Directors | 2021 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kanenas 109 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexander Mikael Carlson Boweden | Board of Directors | 0 companies |
| Claes Bertil Gyllensvaan | Board of Directors | 0 companies |
| Alexander Mikael Carlson | Board of Directors | 0 companies |
| Carl Frans Blom | Deputy Board Member | 0 companies |
| Eva Margareta Gyllensvaan | Deputy Board Member | 0 companies |